SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE

被引:0
作者
Lupusoru, Gabriela Elena [1 ,2 ]
Ailincai, Ioana-Georgiana [2 ]
Sorohan, Bogdan Marian [1 ,2 ]
Andronesi, Andreea Gabriella [1 ,2 ]
Lupusoru, Mircea [3 ]
Andronesi, Danut [4 ]
Manda, Dana [5 ]
Caragheorgheopol, Andra [5 ]
Ismail, Gener [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania
[2] Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Physiol Dept, Bucharest, Romania
[4] Fundeni Clin Inst, Gen Surg & Liver Transplant Dept, Bucharest, Romania
[5] CI Parhon Natl Inst Endocrinol, Res Dept, Bucharest, Romania
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO648
引用
收藏
页码:378 / 378
页数:1
相关论文
共 50 条
[41]   Soluble urokinase plasminogen activator receptor is elevated in diabetes and associated with diabetic complications in patients with type 1 diabetes [J].
Theilade, S. ;
Lyngbaek, S. ;
Hansen, T. W. ;
Eugen-Olsen, J. ;
Fenger, M. ;
Rossing, P. ;
Jeppesen, J. .
DIABETOLOGIA, 2014, 57 :S508-S508
[42]   The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease [J].
Can, Ummugulsum ;
Guzelant, Asuman ;
Yerlikaya, Fatma Humeyra ;
Yosunkaya, Sebnem .
JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (07) :938-943
[43]   Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease [J].
Lv, Li ;
Wang, Fang ;
Wu, Liang ;
Wang, Jin-Wei ;
Cui, Zhao ;
Hayek, Salim S. ;
Wei, Changli ;
Reiser, Jochen ;
He, Kevin ;
Zhang, Luxia ;
Chen, Min ;
Zhao, Ming-Hui .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (03) :465-470
[44]   Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease [J].
Ahmed, Reem M. ;
Khalil, Mona A. ;
Ibrahim, Amal H. ;
Eid, Hanaa M. ;
Abdelbasset, Walid Kamal ;
Soliman, Gaber S. .
MEDICINE, 2019, 98 (38)
[45]   SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE [J].
Yussef, Sarah Mohammed ;
Ursli, Martin ;
Rothschild, Inke ;
Faraj-Allah, Ayah ;
Koppensteiner, Renate ;
Schernthaner, Gerit-Holger ;
Hoebaus, Clemens .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 :161-161
[46]   Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease [J].
Fueller, D. ;
Liu, C. ;
Ko, Y. -A. ;
Alkhoder, A. ;
Desai, S. R. ;
Almuwaqqat, Z. ;
Patel, S. A. ;
Ejaz, K. ;
Kauser, T. ;
Martini, A. ;
Alvi, Z. ;
Mehta, P. K. ;
Sperling, L. S. ;
Quyyumi, A. A. .
EUROPEAN HEART JOURNAL, 2023, 44
[47]   Soluble urokinase plasminogen activator receptor (suPAR) as a serum biomarker for patients undergoing resection of pancreatic adenocarcinoma. [J].
Loosen, Sven H. ;
Binnebosel, Marcel ;
Longerich, Thomas ;
Trautwein, Christian ;
Roderburg, Christoph ;
Neumann, Ulf Peter ;
Luedde, Tom .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[48]   Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia [J].
Genc, Abdullah ;
Kalelioglu, Tevfik ;
Karamustafalioglu, Nesrin ;
Tasdemir, Akif ;
Genc, Esra Sena ;
Akkus, Mustafa ;
Emul, Murat .
PSYCHIATRY RESEARCH, 2016, 236 :179-181
[49]   Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis [J].
Drueke, Tilman B. ;
Massy, Ziad A. .
KIDNEY INTERNATIONAL, 2023, 103 (03) :451-454
[50]   Soluble urokinase plasminogen activator receptor in blood transfusion components [J].
Riisbro, R ;
Brünner, N ;
Christensen, IJ ;
Nielsen, HJ .
TRANSFUSION MEDICINE, 2004, 14 (04) :305-312